Cataract Surgery and Diabetes: Special Considerations

While cataract surgery is one of the safest and most commonly performed procedures in all of medicine, diabetes introduces specific challenges that our cataract surgeons account for during planning and in the operating room. Many diabetic patients experience a condition sometimes called small pupil syndrome, where the iris does not dilate as widely as needed during surgery. A smaller pupil limits the surgeon's view and working space inside the eye. Our cataract surgeons use specialized techniques and iris-expansion devices when necessary to maintain adequate dilation throughout the procedure without compromising safety.

Diabetic eyes tend to produce a stronger inflammatory response after surgery. This heightened inflammation can damage the blood-retinal barrier, the protective boundary that keeps fluid from leaking into the retina. When this barrier breaks down, fluid can accumulate in the macula, the central part of the retina responsible for sharp vision, leading to a condition called pseudophakic cystoid macular edema. Aggressive anti-inflammatory treatment with prescription eye drops before and after surgery helps reduce this risk substantially.

Elevated blood sugar can slow the healing of the tiny incisions made during cataract surgery. While the incisions used in modern phacoemulsification are very small, impaired healing increases the window for potential complications. Maintaining well-controlled glucose levels in the weeks surrounding surgery supports proper wound closure and lowers the chance of issues during recovery.

Diabetes is associated with a modestly increased risk of postoperative infection, including endophthalmitis, a rare but serious infection inside the eye. This risk is related to the immune system changes that accompany chronic high blood sugar. Strict sterile technique and prophylactic antibiotic protocols, which are standard in all cataract surgery procedures, are especially important for diabetic patients.

Most guidelines recommend a fasting blood glucose below 140 mg/dL on the day of surgery, with postprandial levels under 200 mg/dL. A hemoglobin A1C at or below 7 to 8 percent reflects good long-term control and is associated with fewer postoperative complications. Our cataract surgeons weigh the urgency of the cataract against your overall glucose management and individualize the recommendation.

Monofocal intraocular lenses are generally the safest and most predictable choice for patients with any degree of diabetic retinopathy. Multifocal and trifocal IOLs, which split light to provide vision at multiple distances, can reduce contrast sensitivity, which may compound visual quality issues caused by retinal disease. Extended depth of focus lenses may be considered in select patients with very mild or stable retinopathy.

Removing the cloudy lens allows your doctor to see and treat the retina much more effectively, which is a meaningful benefit for ongoing diabetic eye care. Improved visualization after surgery often leads to better monitoring and earlier detection of retinal changes. At the same time, the inflammatory response from surgery can temporarily worsen macular edema in some patients, which is why close postoperative monitoring is essential.

The overall recovery timeline after cataract surgery is similar for diabetic and non-diabetic patients, with most people noticing improved vision within the first few days. However, diabetic patients may experience a slightly longer period before their vision fully stabilizes, particularly if mild macular edema develops after surgery. You will typically use anti-inflammatory and antibiotic eye drops for four to six weeks.

Studies suggest that cataract surgery may be associated with a modest progression of diabetic retinopathy in some patients, particularly those with poorly controlled blood sugar or preexisting retinal disease at the time of surgery. The risk is highest in eyes with active proliferative retinopathy or unstable macular edema. In patients with well-controlled diabetes and stable retinal findings, the risk of meaningful progression is low. Regular postoperative retinal evaluations help catch any changes early so treatment can begin promptly if needed.